Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pulse Wave Diagnosis Helps Estimate Cardiovascular Risk

By HospiMedica International staff writers
Posted on 08 Apr 2014
New software helps clinicians assess future cardiovascular risk by examining the structure of the eye in children.

Researchers at Hospital General de Valencia (Spain), Universitat Politècnica de València (Spain), and the Ophthalmology Unit of the Foundation for the Health and Biomedical Research of the Comunitat Valenciana (FISABIO-Oftalmología Médica, Valencia, Spain) have developed specialized software to make an in-depth study of the retinal microvascular architecture in children born with low birth-weight.

Pediatric patients undergo various noninvasive tests and all of them are interpreted together, giving as a result an approximation of what is happening in the children’s vessels. More...
Among the tests are pulse wave morphology and speed of the blood as it travels through the vessels, and how it returns. Another test is a fundus scan with a nonmydriatic retinal camera to define the caliber and the branching angle of the retinal vessels to understand blood circulation. The measurements can indicate if a child who has a different branching angle could have an increase in blood pressure over the years.

Using the software, the researchers and pediatricians are analyzing the relationship between the various measurements and adult diseases such as hypertension or cardiovascular problems. By learning more about the retinal attributes of these pathologies as they appear in the newborn, the researchers can possibly determine characteristics that could imply a higher cardiovascular risk when the child reaches adulthood.

“Children with intrauterine growth retardation are those who are at a greater risk of developing cardiovascular diseases, such as hypertension or type 2 diabetes,” said Empar Lurbe Ferrer, MD, head of the pediatrics unit at Hospital General de Valencia. “Because of this, we are using the measurements to see if the branching angles of the vessels of children who have intrauterine growth retardation are different than those who do not.”

“This joint work between engineers and pediatricians aims to provide better care for pediatric patients,” said telecommunication engineer Sandra Morales, a researcher at the LabHuman technology center of the Universitat Politècnica de València. “Our system permits us to establish objective connections between different vessels and help clinical staff to detect these pathologies at the earliest stage. As a result they will help give more personalized treatments.”

Related Links:

Hospital General de Valencia
Universitat Politècnica de València
Foundation for the Health and Biomedical Research of the Comunitat Valenciana


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.